Can't work out with this new Hotcopper how to post hence the previous blank posting.
The real question is, if Veyonda gives a good result whether it is with DARRT or Lupin trial and an offer comes in, will Dr Graham sell? I personally would prefer the company develops a successful pipeline of products and become a disruptive drug company and stay in Australia. Again, everything lies with how successful is the trial. An update with the 1200 dosage in DARRT surely would be seen soon.
Will Noxopharm get Traction from Endocyte Sale?, page-3
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $4.773K | 48.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20574 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 38542 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
